Baird Medical's MWA Technology Successfully Applied in Endocrine Procedures

NEW YORK, March 31, 2025 -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") proudly announces the successful utilization of its advanced microwave ablation (MWA) technology in two recent endocrine procedures. These procedures were performed by Dr. Saka Kazeem, MD, a distinguished endocrinologist with over 30 years of clinical experience.

Using Baird Medical's MWA system for the first time, Dr. Kazeem praised its efficiency and seamless integration into clinical practice. "The system is both intuitive and optimizes procedure time, allowing treatments to be more streamlined without compromising patient outcomes," he stated.

Baird Medical remains dedicated to driving innovation in medical technology and promoting the adoption of MWA among healthcare professionals worldwide. "Dr. Kazeem's successful experience highlights the value of our technology in improving clinical workflows and patient care," said Haimei Wu, Chairwoman of Baird Medical. "We are excited to introduce our solutions to more physicians seeking effective, minimally invasive treatment options."

As the Company continues to expand its presence, Baird Medical is committed to collaborating with leading medical professionals and institutions to drive further innovation in microwave ablation technology and its applications.